BAY-2413555
N/A
Report date: 2025/06/10 17:55:07
NME
Base Information
Drug NameBAY-2413555
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A